Patients and doctors in emerging markets are much more likely to use mHealth than those in developed countries — and more payers in emerging markets cover the cost of mHealth than in developed countries.
Why? Existing healthcare is scarce — in many cases, mobile technology is the only (rather than alternative) affordable tool to reach people. The lack of existing infrastructure means fewer entrenched interests, so lower barriers. Change is more welcome.
© 2003 - Tue Oct 27 22:57:54 UTC 2020 PwC. All rights reserved. PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. Please see www.pwc.com/structure for further details.